Clinical usefulness of cardiac biomarkers in hemodynamically stable pulmonary embolism.
Greco
F
F
Ospedale Civile dell' Annunziata, Cosenza, Italy. francesco.greco@virgilio.it
Porto
I
I
D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011237:Predictive Value of Tests; D011655:Pulmonary Embolism / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D013923:Thromboembolism / Q000097:blood / Q000517:prevention & control; D015912:Thrombolytic Therapy; D020246:Venous Thrombosis / Q000097:blood / Q000517:prevention & control; D018497:Ventricular Dysfunction, Right / Q000097:blood* / Q000188:drug therapy / Q000401:mortality
D015415:Biomarkers; D005343:Fibrinolytic Agents; D020097:Natriuretic Peptide, Brain